Clinical Trials Browser

Terminated × Caloric Restriction × Gastrointestinal × Clear all

NCT03676478 2025-12-10

EFECTS

Phase NA Terminated

Gastrointestinal

Esophageal Neoplasms, Postoperative Complications, Muscle Weakness, Sarcopenia